This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In recent years, a fascinating technique known as microdosing has caught the attention of a broad spectrum of individuals, from Silicon Valley’s high-flying tech entrepreneurs to the socially aware millennials and Generation Z. This indicates that its effects could extend beyond the immediate period of ingestion.
million ($650,000) in funding from New Zealand’s Health Research Council (HRC) to conduct a LSD microdosing trial in patients with Major Depressive Disorder (MDD). The data from this study is currently being assembled and MindBio is set to further announce the new findings.
Doctors can offer microdosing schedules thanks to pattern recognition algorithms from AI that scour enormous amounts of data and experiences that psychedelics induce to investigate treatments for a range of conditions, including depression, addiction, and PTSD. Rate this blog post [Total: 2 Average: 5 ] The post A.I.-Designed
For Jessica Thornton, who has lived with treatment-resistant depression since her senior year at high school, psychedelics represent a lifeline. Desperate to find any solution, she tried microdosing psilocybin mushrooms after researching the practice online. I felt as if I was in a constant battle with myself. “I
Data from a nationally representative sample of participants have been collected since 1975 to understand drug use trends among American young adults, and noteworthy findings are published each fall. He is said to have microdosed with LSD for the last 25 years of his life, passing away on April 29, 2008. Talk about mixed signals.
Other strategies include filing patents on synthetic pathways, extraction protocols, novel formulations, methods of use, and methods of treatment in various disease conditions. As we see more data emerge from clinical trials, we are likely to see patent applications covering stability, pharmacokinetic, and pharmacodynamic data.
Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future. Canada and Australia have already passed legislation allowing for MDMA use for mental health treatment. What is MDMA? OK…brace yourself.
In 2011, researchers published cross-sectional data from two population-based surveys including over 50,000 respondents. Prediction 3: The combination of omega-3 supplements and cannabis could be a particularly effective treatment. Are cannabis users really more likely to have better weight-to-height ratios than non-users?
We find out how women and other estrogen-predominant people react differently to cannabis than men and those with more testosterone, and why microdosing is far more effective for the former. That’s always the struggle we have when people want data and research and medical research to establish exactly how something works.
there has never been a better time for new treatment options. Paul is the author of the book Microdosing Psychedelics: A Practical Guide to Upgrade Your Life and the founder and CEO of Third Wave and co-founder of Synthesis. a leading biotech company in the hemp and cannabis industries. in/ronanlevy/. The Third Wave. Payton Nyquvest.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content